LP anti-melanoma potential effect was confirmed in vivo where a significant decrease in the serum levels of angiogenic VEGF and a significant increase in the serum levels of immunostimulatory IL-12 were recorded [29]. This evidence concerns the gene VEGFA and melanoma.